OctariusRx

OCTOBER 3, 2022

Other risk factors for breast cancer include: Taking post-menopausal hormone therapy (especially combined estrogen and progestin therapy). Being overweight or obese, especially if weight is gained after menopause. Join the OctariusRx team in supporting the American Cancer Society and this worthy cause. Being physically inactive.

77

77

Hospital Pharmacy Europe

JUNE 9, 2023

Ribociclib is a cyclin-dependent kinase 4/6 inhibitor, approved in combination with endocrine therapy for treatment of HR+/HER2- advanced or metastatic breast cancer in both pre- and post-menopausal women. However, whether this combination would benefit women with early stage breast cancer remains unclear.

Dosage 98

Dosage Labelling Hospitals 98

The Checkup by Singlecare

AUGUST 11, 2023

Or, it can be due to menopause , which is one of the most common reasons for night sweats. Menopause Menopause is one of the most common causes of night sweats. Perimenopause is the time leading up to menopause. After you go through menopause, hormonal changes occur. But what if you wake up in a sweat?

97

97

Pharmaceutical Technology

MARCH 7, 2023

Perimenopause refers to the stage of menopausal transition when an irregularity in the menstrual cycle symptoms may arise before the last menstrual bleed. Data has also indicated that women are at higher risk of worsening anxiety while transitioning into menopause, Santoro says.

Labelling 52

Labelling Hospitals FDA 52

STAT

FEBRUARY 23, 2023

” A woman’s risk of developing the disease is 1 in 78, according to the  American Cancer Society. Most cases occur in post-menopausal women, with half of all cases occurring in women 63 years or older. Women with breast cancer, family histories of ovarian cancer, or endometriosis are also at higher risk.

Medical Schools 99

Medical Schools Hospitals 99

Pharmaceutical Technology

JUNE 2, 2023

Kicking off this year’s American Society of Clinical Oncology’s (ASCO) conference, Novartis has released data supporting the use of its CDK4/6 inhibitor Kisqali (ribociclib) as an adjuvant treatment for a group of early-stage breast cancer patients.

FDA 52

FDA 52

pharmaphorum

DECEMBER 23, 2020

The American Society of Clinical Oncology (ASCO) annual conference was one of the highlights of the year in cancer research and the fact it was held virtually did not distract from some stunning clinical lung cancer trial results presented by AstraZeneca.

FDA 78

FDA Chemotherapy Compounding Vaccines 78

The Checkup by Singlecare

JANUARY 11, 2024

Hormonal fluctuations that occur during different phases of your menstrual cycle or during pregnancy, breastfeeding, or menopause are all times when you might experience sensitive or itchy nipples,” says Ila Dayananda, MD, MPH, OB-GYN and chief medical officer of Oula Health.

52

52

BuzzRx

DECEMBER 15, 2022

Rosacea is a common skin condition that affects approximately 16 million Americans, according to the Centers for Disease Control and Prevention (CDC) and National Rosacea Society. Anyone can develop rosacea, but the condition is common in middle aged women between the ages of 30 and 60, especially women undergoing menopause.

Insurance 52

Insurance Immunization 52

The Guardian - Pharmaceutical Industry

DECEMBER 17, 2023

Veoza, also known as fezolinetant, is prescription-only and will be available privately from January A “gamechanging” drug that prevents hot flushes and could benefit hundreds of thousands of women has been approved for use in the UK.

89

89

The Guardian - Pharmaceutical Industry

MAY 19, 2023

Experts predict US-approved fezolinetant can be a ‘blockbuster’ for thousands of women in the UK Menopause treatments will be revolutionised by a drug that acts directly on the brain to prevent hot flushes, leading doctors have predicted.

75

75

pharmaphorum

JANUARY 25, 2023

The effect on the family, on their work, on fertility, on menopause, on their partners is very important. Olivia is a comprehensive single, digital source of information integrating all these important aspects of the disease.” Concin particularly wanted to stress Olivia’s reliability. [It]

Chemotherapy 95

Chemotherapy Hospitals 95

The Checkup by Singlecare

OCTOBER 27, 2023

The American Cancer Society explains the most common types of breast cancer : Ductal carcinoma in situ: A non-invasive, pre-invasive, or stage 0 breast cancer in which the cells that line the ducts are cancerous, but they have not reached nearby breast tissue. It can start in the lobules, ducts, nipples, or blood vessels.

Chemotherapy 98

Chemotherapy Insurance Coverage Insurance Communication 98

InCrowd

AUGUST 25, 2022

It is widely known that hormone replacement therapy in post menopausal women increases the risk of breast cancer. The American College of Radiologists and Society of breast Imaging guidelines may be broadly summarized into three categories: 1. The good news is that increased awareness and new mammography guidelines are in development.

52

52

The Checkup by Singlecare

JANUARY 17, 2023

Low testosterone typically strikes women after menopause. Hyperprolactinemia , Endocrine Society. Teens with low testosterone most often complain about tiredness and fatigue rather than sexual dysfunction. Low testosterone symptoms in women. The signs of low testosterone in women are not well-established but may include: Low sex drive.

Chemotherapy 98

Chemotherapy Hospitals FDA 98

The Thyroid Pharmacist

AUGUST 5, 2022

Gastrointestinal Society. seed (hempseed) in the ovariectomized rat model of menopause. Effects of dietary phenylalanine and tyrosine on circulating thyroid hormone levels and growth in the chick. 1980 Jan;110(1):130-8. Published May 20, 2020. Accessed May 31, 2021. Rao R, Samak G. J Epithel Biol Pharmacol. 2012;5(Suppl 1-M7):47-54.

Immunization 98

Immunization Compounding Labelling 98

pharmaphorum

SEPTEMBER 13, 2022

The first and only body-identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by the SMC as suitable for use by Scotland’s National Health Service, after being advised by the NHS Boards and Area Drug and Therapeutics Committees (ADTCs). They are also associated with fewer risks than are synthetic hormones.

Dosage 59

Dosage 59

The Checkup by Singlecare

NOVEMBER 14, 2023

For example, teenagers just beginning their periods and women approaching menopause may have irregular uterine bleeding due to hormone fluctuations, according to the National Library of Medicine. Any post-menopausal woman with vaginal bleeding should visit a healthcare provider right away. appeared first on The Checkup.

Hospitals 52

Hospitals Vaccines 52

The Thyroid Pharmacist

JULY 29, 2022

EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. PBDE flame retardants, thyroid disease, and menopausal status in U.S. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):385-91. Gore AC, Chappell VA, Fenton SE, et al. Endocr Rev.

Health and Personal Care Stores 52

Health and Personal Care Stores Compounding Immunization Labelling 52

The Thyroid Pharmacist

FEBRUARY 10, 2023

Talking about sex makes us blush and isn’t really socially acceptable in our society – thus, many people suffer in silence. In particular for women, times of hormone fluctuation, as seen with menstruation, taking birth control pills, transitioning to menopause, or even pregnancy and breastfeeding, can result in an impact on libido.

Dosage 83

Dosage Documentation FDA Labelling 83

The Checkup by Singlecare

JANUARY 12, 2024

Perimenopause Perimenopause is defined as the years leading up to menopause, which is the cessation of having monthly periods. Irregular bleeding is most common when girls first get their periods and also during the menopause transition (perimenopause). During this transition, irregular periods are common, according to ACOG.

Mayo Clinic 52

Mayo Clinic 52

The Thyroid Pharmacist

JULY 7, 2023

Journal of the International Menopause Society. 2014;74(11):1195-1207. doi:10.1007/s40265-014-0259-8 [58] Ott J et al. Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto’s thyroiditis. 59] Schmeltz, Lowell R.

Immunization 104

Immunization Dosage Compounding Pharmaceutical Companies 104